UNIQUM AS

Keywords

consultingguidanceassistancemanagement issuesstrategicorganizationalreorganizationbusiness procedureschange managementcost reductionpersonnelremunerationpension strategiesproduction planningcontrol planninglobbyingaccounting procedurescost accountingbudget control proceduresrationalizationcontrolmanagement information

Organization

CEO: KM
Kaare Moursund Gisvold1943
Chairman of the board: KM
Kaare Moursund Gisvold1943
Years since formation: 20 years; since Jan 22, 2005
Type: Limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 200; 2 share classes
Total number of shareholders: 6; persons

Financials

Total operating income 2023: 88,444; NOK
Annual total result 2023: 2,413,759; NOK
Total equity 2023: 20,741,370; NOK

Last update: Aug 29, 2024

Management

Management / administration

Name	Role	Shares
KM Kaare Moursund Gisvold 1943	Managing Director/CEO	-

Board

Name	Role	Shares
KM Kaare Moursund Gisvold 1943	Chairman	-
EG Elisabeth Gisvold 1968	Alternate Member	19.5 % directly

Others

Name	Role	Shares
S SPAREBANK 1 REGNSKAPSHUSET SMN AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
MG Marianne Gisvold 1963	-	20 % directly
BG Birgitte Gisvold Johannessen 1973	-	20 % directly
MG Merete Gisvold Sandberg 1971	-	20 % directly
KR Kristian Rathe Gisvold 1991	-	20 % directly
EG Elisabeth Gisvold 1968	Alternate Member	19.5 % directly

Last update: Apr 13, 2023

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
BG Birgitte Gisvold Johannessen 1973	Class B shares	40	20 %
KR Kristian Rathe Gisvold 1991	Class B shares	40	20 %
MG Marianne Gisvold 1963	Class B shares	40	20 %
MG Merete Gisvold Sandberg 1971	Class B shares	40	20 %
EG Elisabeth Gisvold 1968	Class B shares	39	19.5 %
KM Kaare Moursund Gisvold 1943	A-shares	1	0.5 %

Shares owned by the UNIQUM AS

Name	Share class	Total number of shares	Share
P PROVENTURE SEED II AS	Ordinary shares	2,474,110	0.54 %
P PHARMASUM THERAPEUTICS AS	Ordinary shares	1,439	0.05 %
A AMICOAT AS	NO0010799679	15,282	0.04 %
L LYTIX BIOPHARMA AS	NO0010405780	30,650	0.04 %
P POLARIS MEDIA ASA	NO0010466022	20,090	0.04 %
O OKEA ASA	NO0010816895	27,450	0.03 %
P PHARMA HOLDINGS AS	NO0010797350	305	0.03 %
S SPAREBANK 1 SMN	NO0006390301	23,182	0.02 %
O ORKLA ASA	NO0003733800	20,003	< 0.01 %
N Norsk Hydro ASA	NO0005052605	50,090	< 0.01 %
N NORDIC SEMICONDUCTOR ASA	NO0003055501	8,700	< 0.01 %
T TELENOR ASA	NO0010063308	9,700	< 0.01 %
A AKER BP ASA	NO0010345853	9,500	< 0.01 %
K KONGSBERG GRUPPEN ASA	NO0003043309	4,600	< 0.01 %

Last update: Jun 2, 2025

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	88,444	0	0
Annual Total Result	2,413,759	231,498	7,651,734
Total assets	20,862,722	18,548,462	18,416,464
Total liabilities	121,351	121,351	121,351
Total equity	20,741,370	18,427,111	18,295,113

P&L

Year	2023	2022	2021
Total operating income	88,444	0	0
Total operating costs	253,328	155,516	147,544
Operating result	-164,884	-155,516	-147,544
Financial income/costs	2,583,683	387,014	7,799,278
Profit before tax	2,418,799	231,498	7,651,734
Total tax & extraordinary income/cost	5,040	0	0
Annual Total Result	2,413,759	231,498	7,651,734

Balance overview

Year	2023	2022	2021
Total fixed assets	2,696,284	2,831,370	2,034,305
Total current assets	18,166,438	15,717,093	16,382,159
Total assets	20,862,722	18,548,462	18,416,464
Short term debt	121,351	121,351	121,351
Long term debt	0	0	0
Total liabilities	121,351	121,351	121,351
Contributed capital	200,280	200,280	200,280
Retained earnings	20,541,090	18,226,831	18,094,833
Total equity	20,741,370	18,427,111	18,295,113
Total equity and liabilities	20,862,722	18,548,463	18,416,464

UNIQUM AS987 689 250

UNIQUM AS

Keywords

Organization

Ownership

Financials

Management

Management / administration

Board

Others

Top 10 individual shareholders

Ownership

Company shareholders

Shares owned by the UNIQUM AS

Financials

Summary

P&L

Balance overview

Classification